| mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.07 |
| mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.08 |
| mRNA |
MGCD-265 |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.08 |
| mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.08 |
| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.08 |
| mRNA |
CR-1-31B |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.09 |
| mRNA |
palmostatin B |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.09 |
| mRNA |
BRD-K17060750 |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.09 |
| mRNA |
BRD-K37390332 |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.09 |
| mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.09 |